Table 3.
Summary of patients with unsuccessful removal of central venous access parts
Patient No. |
Gender | Age*1
(years) |
BMI (kg/m2) |
Diagnosis | Indwelling side | Venous placement site | Type of CV port | Indication for removal | Indwelling period (months) | Removal procedure*3 | Follow-up period*4 (months) | Symptomatic late complication*5 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(1)–(4) | (5) | (6) | (7) | ||||||||||||
1 | M | 66 | 25.4 | Lymphoma | L | Basilic | DewX | CR | 41 | + | + | 8 | None | ||
2 | F | 88 | 21.3 | Lymphoma | L | Basilic | DewX | Infection*2 | 49 | + | + | + | 28 | None | |
3 | F | 48 | 18.4 | Leukemia | L | Basilic | Vital-Port | Other | 58 | + | + | 60 | None | ||
4 | F | 49 | 19.2 | Laryngeal Ca | L | Basilic | DewX | CR | 62 | + | + | 7 | None | ||
5 | F | 42 | 19.9 | Lymphoma | L | Brachial | X-Port | CR | 70 | + | + | 36 | None | ||
6 | F | 68 | 25.1 | Lymphoma | L | Basilic | Vital-Port | CR | 70 | + | + | + | 36 | None | |
7 | M | 77 | 24.1 | Pharyngeal Ca | L | Basilic | Vital-Port | CR | 70 | + | + | 33 | None | ||
8 | M | 45 | 21.5 | Lymphoma | L | Basilic | Vital-Port | CR | 78 | + | + | 23 | None | ||
9 | F | 71 | 18.3 | Lymphoma | L | Basilic | X-Port | CR | 80 | + | + | 9 | None | ||
10 | M | 39 | 23.9 | Lymphoma | L | Cephalic | Vital-Port | CR | 83 | + | + | 21 | None | ||
11 | F | 70 | 20.9 | Lymphoma | L | Basilic | Vital-Port | CR | 83 | + | + | 28 | None | ||
12 | M | 69 | 23.2 | Extra-auditory Ca | L | Brachial | Vital-Port | CR | 84 | + | + | 41 | None | ||
13 | F | 44 | 22.9 | Ovarian Ca | L | Basilic | Vital-Port | CR | 87 | + | + | 58 | None | ||
14 | F | 56 | 31.2 | Myeloma | L | Basilic | Vital-Port | Occlusion | 91 | + | 41 | None | |||
15 | M | 69 | 21.0 | Lymphoma | L | Basilic | Vital-Port | CR | 98 | + | + | 2 | None | ||
16 | F | 53 | 19.7 | Lymphoma | L | Basilic | Vital-Port | Occlusion | 99 | + | + | + | + | 54 | None |
17 | M | 67 | 24.6 | Lymphoma | L | Basilic | Celsite port | Infection*2 | 109 | + | + | + | + | 10♰ | None |
18 | F | 78 | 20.0 | Lymphoma | L | Basilic | Vital-Port | Breakage | 138 | + | 3 | None |
M male, F female, BMI body mass index, Ca carcinoma, L left, CV port central venous access port, CR complete response Vital-Port Mini Titanium Vital-Port, X-Port BARD X-Port, Celsiteport P-U Celsiteport
*1Age at removal of CV port
*2Possibility of infection from CV port
*3Refer to Materials and methods in the text for details of the removal procedure in (1)–(7)
*4The period after attempt to remove the CV port
*5The complication related to the catheter left in place
♰Died due to aggravated underlying disease